v3.26.1
FAIR VALUE
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
FAIR VALUE FAIR VALUE
The Company uses fair value measurements to record fair value adjustments to certain assets and to determine fair value disclosures. Fair value represents the estimated exchange price that would be received from selling an asset or paid to transfer a liability, otherwise known as an “exit price,” in the principal or most advantageous market available to the entity in an orderly transaction between market participants on the measurement date.
Fair Value Hierarchy
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company groups financial assets and financial liabilities measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are:
•Level 1—Quoted prices for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
•Level 2—Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
•Level 3—Significant unobservable inputs that reflect management’s judgment and assumptions that market participants would use in pricing an asset or liability that are supported by little or no market activity.
In general, fair value is based upon quoted market prices, where available. If such quoted market prices are not available, fair value is based upon internally developed models that primarily use, as inputs, observable market-based parameters. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value. These adjustments may include amounts to reflect counterparty credit quality and our creditworthiness, among other things, as well as unobservable parameters. Any such valuation adjustments are applied consistently over time. Our valuation methodologies may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. While management believes our valuation methodologies are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. Furthermore, the reported fair value amounts have not been comprehensively revalued since the presentation dates, and therefore, estimates of fair value after the balance sheet date may differ significantly from the amounts presented herein. A more detailed description of the valuation methodologies used for certain assets and liabilities measured at fair value is set forth below.
The carrying amounts and estimated fair values of financial instruments that are reported on the balance sheet were as follows:
March 31, 2026
Carrying
Amount		Estimated Fair Value
Level 1Level 2Level 3Total
(In thousands)
Financial assets
Cash and cash equivalents$549,570 $549,570 $— $— $549,570 
Available for sale securities1,864,710 — 1,864,710 — 1,864,710 
Loans held for investment, net of allowance7,502,521 — — 7,471,807 7,471,807 
Accrued interest receivable36,589 499 7,687 28,403 36,589 
Financial liabilities
Deposits$8,982,010 $— $8,979,347 $— $8,979,347 
Accrued interest payable5,240 — 5,240 — 5,240 
Borrowed funds135,000 — 135,000 — 135,000 
Subordinated debt40,256 — 40,239 — 40,239 
December 31, 2025
Carrying
Amount		Estimated Fair Value
Level 1Level 2Level 3Total
(In thousands)
Financial assets
Cash and cash equivalents$419,453 $419,453 $— $— $419,453 
Available for sale securities2,198,459 — 2,198,459 — 2,198,459 
Loans held for investment, net of allowance7,216,962 — — 7,203,747 7,203,747 
Accrued interest receivable35,869 294 7,950 27,625 35,869 
Financial liabilities
Deposits$9,021,466 $— $9,019,219 $— $9,019,219 
Accrued interest payable5,508 — 5,508 — 5,508 
Subordinated debt40,226 — 40,473 — 40,473 
The following tables present fair values for assets and liabilities measured on a recurring basis:
March 31, 2026
Level 1Level 2Level 3Total
(In thousands)
Financial assets
 Available for sale securities:
U.S. government and agency securities$— $87,645 $— $87,645 
Municipal securities— 193,619 — 193,619 
Agency mortgage-backed pass-through securities— 805,887 — 805,887 
Agency collateralized mortgage obligations— 673,985 — 673,985 
Corporate bonds and other— 103,574 — 103,574 
Interest rate swaps and caps— 4,114 — 4,114 
Credit risk participation agreements— — 6 6 
Total fair value of financial assets$— $1,868,824 $6 $1,868,830 
Financial liabilities
Interest rate swaps and caps$— $4,114 $— $4,114 
Total fair value of financial liabilities$— $4,114 $— $4,114 
December 31, 2025
Level 1Level 2Level 3Total
(In thousands)
Financial assets
 Available for sale securities:
U.S. government and agency securities$— $392,475 $— $392,475 
Municipal securities— 196,201 — 196,201 
Agency mortgage-backed pass-through securities— 807,986 — 807,986 
Agency collateralized mortgage obligations— 697,065 — 697,065 
Corporate bonds and other— 104,732 — 104,732 
Interest rate swaps and caps— 4,252 — 4,252 
Credit risk participation agreements— — 6 6 
Total fair value of financial assets$— $2,202,711 $6 $2,202,717 
Financial liabilities
Interest rate swaps and caps$— $4,252 $— $4,252 
Total fair value of financial liabilities$— $4,252 $— $4,252 
There were no transfers between levels during the three months ended March 31, 2026 or 2025.
Certain assets, including purchase credit deteriorated and individually evaluated loans with allowances for credit losses and foreclosed assets and branch assets held for sale, are measured at fair value on a nonrecurring basis. These assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments in certain circumstances such as impairment. There were no liabilities measured at fair value on a nonrecurring basis at March 31, 2026 and December 31, 2025.
Assets measured on a nonrecurring basis for the periods noted are summarized in the table below:
March 31, 2026
Level 1Level 2Level 3
(In thousands)
Loans:
Commercial and industrial$— $— $11,242 
Commercial real estate construction and land development
— — 12,505 
Residential construction— — 5,139 
Foreclosed assets— — 9,454 
Total$— $— $38,340 
December 31, 2025
Level 1Level 2Level 3
(In thousands)
Loans:
Commercial and industrial$— $— $10,528 
Commercial real estate construction and land development
— — 10,377 
Consumer and other— — 6,203 
Foreclosed assets— — 7,492 
Total$— $— $34,600